Regeneron Pharmaceuticals, Inc. (Regeneron) is a biopharmaceutical company that discovers, develops and commercializes pharmaceutical products for the treatment of serious medical conditions. As of December 31, 2008, the Company had one marketed product: ARCALYST (rilonacept) Injection for Subcutaneous Use, which is available for prescription in the United States for the treatment of cryopyrin-associated periodic syndromes (CAPS), including familial cold auto-inflammatory syndrome (FCAS) and muckle-wells syndrome (MWS) in adults and children aged 12 and older. Regeneron also has six clinical development ...


There are no scholarships at this time


There are no events at this time

Company Data on Regeneron
provided by Owler


Regeneron is hiring for these positions

Show me: All available jobs